These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3223399)

  • 1. Modification of tumor cells and its application to immunotherapy of tumor metastasis.
    Kobayashi H
    Adv Exp Med Biol; 1988; 233():97-108. PubMed ID: 3223399
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease.
    Poste G; Kirsh R
    Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.
    Tamura Y; Peng P; Liu K; Daou M; Srivastava PK
    Science; 1997 Oct; 278(5335):117-20. PubMed ID: 9311915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour dormancy: initiation, maintenance and termination in animals and humans.
    Stewart TH; Hollinshead AC; Raman S
    Can J Surg; 1991 Aug; 34(4):321-5. PubMed ID: 1868387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin contact immunotherapy of local and metastatic deposits of rat tumors.
    Baldwin RW; Hopper DG; Pimm MV
    Ann N Y Acad Sci; 1976; 277(00):124-34. PubMed ID: 1069545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of lymphocytes sensitized in vitro against tumor cells.
    Treves AJ; Cohen IR; Schechter B; Feldman M
    Ann N Y Acad Sci; 1976; 276():165-75. PubMed ID: 1088382
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM; Riggs CW; Hanna MG
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract]   [Full Text] [Related]  

  • 8. Patrolling monocytes control tumor metastasis to the lung.
    Hanna RN; Cekic C; Sag D; Tacke R; Thomas GD; Nowyhed H; Herrley E; Rasquinha N; McArdle S; Wu R; Peluso E; Metzger D; Ichinose H; Shaked I; Chodaczek G; Biswas SK; Hedrick CC
    Science; 2015 Nov; 350(6263):985-90. PubMed ID: 26494174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and functional aspects of active specific immunotherapy of established pulmonary metastases in guinea pigs.
    Hanna MG; Peters LC
    Cancer Res; 1981 Oct; 41(10):4001-9. PubMed ID: 7285011
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor heterogeneity, invasion and metastasis. June 3-5, 1981, Saskatoon, Sask., Canada.
    Kerbel RS
    Invasion Metastasis; 1982; 2(1):61-75. PubMed ID: 7188392
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological regression of metastatic tumor cells after surgical excision of primary tumor (author's transl)].
    Katoh H
    Hokkaido Igaku Zasshi; 1982 Jan; 57(1):37-46. PubMed ID: 7076108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating combinations of costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy.
    Hornig N; Reinhardt K; Kermer V; Kontermann RE; Müller D
    Cancer Immunol Immunother; 2013 Aug; 62(8):1369-80. PubMed ID: 23715927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approaches to the adoptive immunotherapy of cancer.
    Yang JC; Rosenberg SA
    Adv Exp Med Biol; 1988; 233():459-67. PubMed ID: 3265581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of immunologic competence of the host on metastases induced by the 3LL Lewis tumor in mice.
    Carnaud C; Hoch B; Trainin N
    J Natl Cancer Inst; 1974 Feb; 52(2):395-9. PubMed ID: 4816002
    [No Abstract]   [Full Text] [Related]  

  • 15. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
    Stagg J; Divisekera U; Duret H; Sparwasser T; Teng MW; Darcy PK; Smyth MJ
    Cancer Res; 2011 Apr; 71(8):2892-900. PubMed ID: 21292811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of macrophage-augmenting factors encapsulated in liposomes for destruction of tumor metastases.
    Schroit AJ; Fidler IJ
    Prog Clin Biol Res; 1982; 102 pt A():347-55. PubMed ID: 7167445
    [No Abstract]   [Full Text] [Related]  

  • 17. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIGB-247: a VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors.
    Bequet-Romero M; Morera Y; Ayala-Ávila M; Ancizar J; Soria Y; Blanco A; Suárez-Alba J; Gavilondo JV
    Vaccine; 2012 Feb; 30(10):1790-9. PubMed ID: 22240345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of immunosuppression for tumor growth and tumor propagation in an allogeneic study].
    Dorschner W; Schönfelder M
    Z Urol Nephrol; 1978 Oct; 71(10):747-52. PubMed ID: 735469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.